← Back to Search

Acceptance and Commitment Therapy for PTSD (ACT-SS Trial)

N/A
Waitlist Available
Led By Megan Marie Kelly, PhD MS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Competent to provide written informed consent
Current DSM-5 PTSD diagnosis
Must not have
Current manic episode
Cognitive impairment that would interfere with study participation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, end of treatment (12 weeks), 3-month follow-up, and 6-month follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether a treatment focused on helping veterans with PTSD to increase social support will be more effective than a common treatment for social support difficulties.

Who is the study for?
This trial is for Veterans aged 18+ with PTSD who struggle in social relationships. They must have a stable medication regimen for at least 2 months, be willing to be recorded, and score at least 31 on the PCL-5 scale. It's not open to those with recent suicidality, cognitive impairments, severe domestic violence issues, ongoing PTSD therapy or manic episodes, substance abuse within the last month, or any psychotic disorders.
What is being tested?
The study compares Acceptance and Commitment Therapy (ACT-SS), aimed at improving social support among veterans with PTSD by addressing interpersonal difficulties and avoidance behaviors against Present-Centered Therapy (PCT). The trial involves randomly assigning participants into two groups of 75 each to test which therapy is more effective.
What are the potential side effects?
While specific side effects are not listed for therapies like ACT-SS and PCT as they are psychological treatments rather than drugs; participants may experience emotional discomfort discussing traumatic events or changing long-standing behavior patterns.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am able to understand and sign the consent form.
Select...
I have been diagnosed with PTSD.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently experiencing a manic episode.
Select...
My thinking or memory problems do not prevent me from participating in studies.
Select...
I am currently undergoing therapy for PTSD.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, end of treatment (12 weeks), 3-month follow-up, and 6-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, end of treatment (12 weeks), 3-month follow-up, and 6-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in the MOS Social Support Survey
Change in the Social Adjustment Scale-Self Report
Secondary study objectives
Change in the Clinician Administered PTSD Scale (CAPS-5)
Change in the PTSD Checklist (PCL-5)
Change in the Quality of Life, Enjoyment, and Satisfaction Questionnaire

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Acceptance and Commitment Therapy to Improve Social SupportExperimental Treatment1 Intervention
This treatment is designed to help Veterans with PTSD increase social support in family, partner, and peer relationships by reducing experiential avoidance. ACT-SS is specifically designed to address deficits in the entire social support network for Veterans with PTSD.
Group II: Present-Centered TherapyActive Control1 Intervention
PCT is designed to provide the emotional support for individuals with PTSD that will assist with recovery. The focus of PCT is on the "here and now," including current life difficulties that are directly or indirectly related to the experience of trauma. PCT aims to help the patient consider ways to react to these difficulties.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,668 Total Patients Enrolled
Megan Marie Kelly, PhD MSPrincipal InvestigatorVA Bedford HealthCare System, Bedford, MA

Media Library

Acceptance and Commitment Therapy to Improve Social Support for Veterans with PTSD Clinical Trial Eligibility Overview. Trial Name: NCT04567680 — N/A
PTSD Research Study Groups: Present-Centered Therapy, Acceptance and Commitment Therapy to Improve Social Support
PTSD Clinical Trial 2023: Acceptance and Commitment Therapy to Improve Social Support for Veterans with PTSD Highlights & Side Effects. Trial Name: NCT04567680 — N/A
Acceptance and Commitment Therapy to Improve Social Support for Veterans with PTSD 2023 Treatment Timeline for Medical Study. Trial Name: NCT04567680 — N/A
~26 spots leftby Nov 2025